Benzinga | May 5, 2021 04:22PM EDT

10x Genomics Q1 EPS $(0.11) Beats $(0.27) Estimate, Sales $105.82M Beat $102.51M Estimate

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.27) by 59.26 percent. This is a 50 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $105.82 million which beat the analyst consensus estimate of $102.51 million by 3.23 percent. This is a 47.17 percent increase over sales of $71.91 million the same period last year.